Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Ichor Life Sciences Expands Ichor Clinical to Australia, Europe, and UK


News provided by

Ichor Life Sciences

Jan 24, 2024, 14:00 ET

Share this article

Share toX

Share this article

Share toX

Ichor Life Sciences
Ichor Life Sciences

Ichor Life Sciences, a full-service, end-to-end contract research organization (CRO) and longevity biotechnology company, announces the expansion of Ichor Clinical's services to Australia, Europe, and the United Kingdom.

LAFAYETTE, N.Y., Jan. 24, 2024 /PRNewswire-PRWeb/ -- Ichor Life Sciences, a full-service, end-to-end contract research organization (CRO) and longevity biotechnology company, has set the stage for an exciting global advance in clinical trial services. Today, the company announced the expansion of Ichor Clinical's services to Australia, Europe, and the United Kingdom.

Pioneering a forward-thinking approach to enhance accessibility to international research and strategy, Ichor Life Sciences is ensuring that biotechnology and pharmaceutical companies have access to a world of possibilities. Lisa Sonneborn, MA, LMHC, President of Ichor Clinical, stated, "Our mission is to act as a global catalyst, offering personalized global clinical trial services, strategy, and regulatory guidance to life sciences companies of all sizes, including small and medium-sized companies that require a superior level of service."

"Our mission is to act as a global catalyst, offering personalized global clinical trial services, strategy, and regulatory guidance to life sciences companies of all sizes." - Lisa Sonneborn, MA, LMHC, President of Ichor Clinical

Post this

Establishing collaborative processes and service offerings with concierge and boutique CROs in Australia, the UK, and Ireland, Ichor Clinical brings an array of innovative solutions to pharmaceutical and biotechnology companies worldwide. Their services include trial design and startup, clinical trial site selection, recruitment planning and strategy, monitoring, data management and statistics, regulatory support, and trial close out. Ichor Clinical is growing an alliance of CROs with geographic expertise and varying cultural perspectives for clients seeking the opportunity to bring global strategy and trial execution to their asset pipeline.

Dr. Tina Soulis, PhD, Founder and Director of Alithia Life Sciences, a full-service capability Australian CRO, emphasizes a unique strategic advantage for clients. Dr. Soulis said, "CROs that grasp the financial and operational benefits of early-stage clinical data in strategically selected countries can provide a distinct financial benefit to their clients, while also allowing for a seamless transition from early phase trials in Australia to later phase trials in the U.S."

The collaboration is spearheaded by a seasoned team with leadership experience spanning every facet of the clinical trial pipeline. Dr. Nicola Wall, PhD, Founder and CEO of Afortiori Development, a full-service CRO based in Ireland and the UK, underscored the commitment to excellence, stating, "Our international strategy ensures bespoke, high-quality services for clinical trials, transcending geographical boundaries and navigating local regulatory and clinical landscapes. We are dedicated to maintaining consistently high standards globally, contributing effectively to the forefront of medical research advancements."

Ichor Life Sciences is committed to innovation and paving the way for global collaboration in medical research and specifically in clinical trials. The addition of international services further solidifies its dedication to excellence and high-quality outcomes for valued customers regardless of their trial experience or resources.

About Ichor Life Sciences

Ichor Life Sciences is a full-service, end-to-end contract research organization (CRO) and longevity biotechnology company. Founded in 2013 in Upstate New York, Ichor's CRO services help biotechnology and pharmaceutical companies solve their most difficult challenges—from preclinical studies to late-stage clinical trials and FDA approval—using a personalized approach that puts relationships and science first.

As a longevity biotechnology company, Ichor aims to help people live longer, healthier lives by developing therapies with the potential to treat age-related diseases. It is the first and oldest longevity-focused venture studio, as well as home to the oldest industry PhD program for drug discovery for longevity. By bringing together its expertise in drug development and as a CRO within its venture portfolio, Ichor is developing promising treatments that have the potential to transform how we age and address unmet needs in the process.

With its breadth of expertise, Ichor is pioneering the longevity and anti-aging biotechnology industry while empowering CRO clients to rapidly advance their research and development programs. To learn more, please visit https://ichorlifesciences.com/ and follow Ichor Life Sciences on LinkedIn.

Media Contact

Virgie Townsend, Ichor Life Sciences, 315-802-6056, [email protected], https://ichorlifesciences.com/

SOURCE Ichor Life Sciences

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.